ALS
Remembering Oren Nahari: The storyteller who brought the world into Israeli living rooms - comment
Oren had an extraordinary ability to teach, but above all, to convey one fundamental message: the most important thing is knowing how to tell a story. There is an audience for it.
Journalist Oren Nahari dies at 70 after battle with ALS
Grapevine, June 24, 2026: Reliving the nightmare - opinion
'Nothing is inevitable': Veteran journalist Oren Nahari on Israel, history, and battle with ALS
Hillel's Tech Corner: NeuroSense: What ALS patients deserve
NeuroSense Therapeutics is a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Israeli biotech firm's ALS treatment shows safety of use in trials
The objective of this trial was to evaluate the safety of their treatment, with a secondary objective of the trial of estimating its preliminary efficacy.
Investigational drug proven to prolong survival of ALS patients - study
The median overall survival for all CENTAUR study participants being administered AMX0035 was 6.5 months longer than the group originally randomized to placebo.
Israeli biotech firm's ALS treatment shows positive results in trials
"We are now focused on advancing strategic FDA regulatory processes that will necessitate the conduct of global multi-center clinical trials."
Israeli treatment could delay deadly effects of ALS – new study
AstroRx is a cell therapy product containing functional healthy astrocytes derived from human embryonic stem cells that aim to protect diseased motor neurons.
Rabbi suffering from ALS makes cross-country trip for son’s bar mitzvah
Rabbi Yitzi Hurwitz, 47, writes a weekly commentary on the Torah and a blog offering marriage advice.
ALS patient gets death wishes for planning to undergo treatment in Israel
"Some people enjoy insulting Paolo," said his brother to local media. "They look for any way to sabotage his actions."
Learning to focus with Dina Hurwitz
Dina was driving the older children from school in LA on a Friday when Yitzi phoned with the dread diagnosis. It was his 41st birthday.
Ben-Gurion University unveils AI platform for predicting ALS progression
There is currently neither a cure nor an effective treatment to halt or reverse the progressive disease.
Meet the Israeli company optimistic about beating ALS
NeuroSense is planning to commence clinical trials later this year in the United States and Israel.
